Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2010
03/25/2010US20100077514 Gene Expression Modulating Element
03/25/2010US20100077513 Novel plant transcribed regions and uses thereof
03/25/2010US20100077509 Nucleic acid molecules encoding plant proteins in the c3hc4 family and methods for the alteration of plant cellulose and lignin content
03/25/2010US20100077508 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
03/25/2010US20100077507 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
03/25/2010US20100077506 Peroxidase Gene Nematode Inducible Promotors and Methods of Use
03/25/2010US20100077505 Auxin Transport Proteins
03/25/2010US20100077504 Temporal seed promoters for expressing genes in plants
03/25/2010US20100077503 Transferases, Epimerases, Polynucleotides Encoding These and Uses Thereof
03/25/2010US20100077498 Compositions and methods for blood-brain barrier delivery in the mouse
03/25/2010US20100077497 Ip-10 antibodies and their uses
03/25/2010US20100077496 MO-1, A Gene Associated With Morbid Obesity
03/25/2010US20100077494 Ungulates with Genetically Modified Immune Systems
03/25/2010US20100077492 Oxidative DNA Damage Protection
03/25/2010US20100076185 Selective Processing of Biological Material on a Microarray Substrate
03/25/2010US20100076184 Gbs toxin receptor
03/25/2010US20100076183 Protected monomer and method of final deprotection for rna synthesis
03/25/2010US20100076176 Sweetener Preparations and Methods of Use
03/25/2010US20100076062 Use of a Truncated eIF-5A1 Polynucleotide to Induce Apoptosis in Cancer Cells
03/25/2010US20100076060 Aptamers as agonists
03/25/2010US20100076056 MODIFIED iRNA AGENTS
03/25/2010US20100076054 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
03/25/2010US20100076053 Sequence of dsrna: atn-rna, intervention using irnai, use of a sequence of dsrna: atn-rna, a method of treating and inhibiting a brain tumor, a kit for inhibiting cancer cell which expresses tenascin, a method for a kit preparation in a brain tumor therapy
03/25/2010US20100075898 N-terminal vdac variants and uses thereof
03/25/2010US20100075891 Novel polynucleotides encoding polypeptides and methods using same
03/25/2010US20100075869 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
03/25/2010US20100075861 4c
03/25/2010US20100075434 Method for detecting target substance, and tag, DNA, vector, probe and detection kit for use therewith
03/25/2010US20100075423 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
03/25/2010US20100075402 DNA coding for polypeptide fusion
03/25/2010US20100075397 Enzyme involved in biosynthesis of plant-protective phytochemical; catalyzes conversion of fatty acid hydroperoxide intermediates to divinyl ether fatty acids, bioactive oxylipins for biological pest control of phytopathogens such as late blight
03/25/2010US20100075393 Aqueous microfabrication of functional bioelectronic architectures
03/25/2010US20100075387 microbial oils; nutraceuticals, foods, and animal feeds
03/25/2010US20100075386 Mutant delta-5 desaturases and their use in making polyunsaturated fatty acids
03/25/2010US20100075385 O-Methyltransferases of Tetrahydrobenzylisoquinoline Alkaloid Biosynthesis in Papaver Somniferum
03/25/2010US20100075382 Ssb-polymerase fusion proteins
03/25/2010US20100075380 Novel Lipase
03/25/2010US20100075378 Moraxella catarrhalis basb115 polypeptides
03/25/2010US20100075363 Recombinant Yeast Strains Expressing Tethered Cellulase Enzymes
03/25/2010US20100075343 Novel peptides
03/25/2010US20100075320 Paxillin mutations, methods of assessing risk of metastasis and methods of staging tumors
03/25/2010US20100075318 Method of determining the haplotype of multiple allelic genes
03/25/2010US20100075313 Device for the lysis of microorganisms present in an environmental or clinical sample and the extraction of nucleic acids from said microorganisms for analysis
03/25/2010US20100075302 Assays for Resistance to Echinocandin-Class Drugs
03/25/2010US20100074995 Poplar transcription factors
03/25/2010US20100074991 Novel oxidoreductases and uses thereof
03/25/2010US20100074945 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes
03/25/2010US20100074925 Antigen specific multi epitope vaccines
03/25/2010US20100074920 Peptide vaccine for influenza virus
03/25/2010US20100074919 Circovirus sequences associated with piglet weight loss disease (PWD)
03/25/2010US20100074916 Avian influenza vaccine
03/25/2010US20100074908 Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses
03/25/2010US20100074906 Antibodies Specific for Varicella Zoster Virus
03/25/2010US20100074901 Human anti-amyloid antibodies, compositions, methods and uses
03/25/2010US20100074900 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
03/25/2010US20100074892 Monoclonal Antibodies That Neutralize Anthrax Protective Antigen (PA) Toxin
03/25/2010US20100074887 Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases
03/25/2010US20100074866 Interferon alpha mutant and its polyethylene glycol derivative
03/25/2010US20100074845 Enhanced sensitivity carbon nanotubes as targeted photoacoustic molecular imaging agents
03/25/2010DE69029370C5 Erythropoietin-Isoformen Erythropoietin isoforms
03/25/2010CA2738625A1 Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications
03/24/2010EP2166096A2 Moraxella (Branhamella) catarrhalis antigens
03/24/2010EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells
03/24/2010EP2166017A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
03/24/2010EP2164996A2 Riboswitches and methods and compositions for use of and with riboswitches
03/24/2010EP2164857A1 Fluorescent labeling of transfer rna and study of protein synthesis
03/24/2010EP1697403B1 Haemophilus influenzae type iv pili
03/24/2010EP1492805B1 System for tracing animal products
03/24/2010CN101679978A hydroxymethyl substituted rna oligonucleotides and rna complexes
03/24/2010CN101679506A Compositions and methods for binding sphingosine-1-phosphate
03/24/2010CN101679475A Improved vaccines and methods for using the same
03/24/2010CN101679474A synthesis of oligonucleotides
03/24/2010CN101679473A Nanoplasmonic molecular ruler for nuclease activity and DNA footprinting
03/24/2010CN101677537A disintegrin variants and pharmaceutical uses thereof
03/24/2010CN101676728A cytokine receptor
03/24/2010CN100595211C Angiopoietin-2 specific binding agents
03/24/2010CN100594930C Medicinal composition using anterior pituitary adrenal cortical extract as main component, and its preparation method and use
03/23/2010US7683237 Maize seed with synergistically enhanced lysine content
03/23/2010US7683166 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
03/23/2010US7683165 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683036 especially nucleic acid and nucleic acid-like oligomers, which are targeted to or mimic nucleic acids comprising or encoding small non-coding RNAs, and which act to modulate the levels of small non-coding RNAs, or interfere with their function
03/23/2010US7683035 Method of stabilizing and/or isolating nucleic acids
03/23/2010US7682818 Cylindrical syringe comprised of solid phase organic polymer for use in separation and isolation of nucleotide sequences
03/23/2010US7682809 nucleic acid sequencing by contacting a nucleic acid duplex comprising a nucleic acid template and a primer annealed to the template with a reagent mix under primer extension conditions to produce an extended primer and ATP; release of pyrophosphate (PPi) indicates that a reaction has occurred
03/23/2010US7682792 using amplification oligomers and polymerase; hybridization; efficient and sensitive; useful in determining efficacy of vaccination
03/23/2010US7682790 Aqueous solution containing cationic stabilizer; plasmids; genomes; kits
03/23/2010US7682789 Method for quantifying biomolecules conjugated to a nanoparticle
03/23/2010US7682788 Method and apparatus for improved luminescence assays using microparticles
03/23/2010US7682787 Using UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T3) to identify modulators for prevention and treatment of familial tumoral calcinosis (FTC)
03/23/2010CA2679750A1 Methods for detecting nucleic acids in a sample
03/23/2010CA2283535C Glycine transporter
03/23/2010CA2194797C Nucleic acid containing composition, preparation and uses of same
03/23/2010CA2193101C Simultaneous detection, identification and differentiation of eubacterial taxa using a hybridization assay
03/18/2010WO2010030849A1 Compositions and methods for treating cancer,inhibiting proliferation, and inducing cell death
03/18/2010WO2010006144A3 Influenza hemagglutinin and neuraminidase variants
03/18/2010WO2009152500A3 Methods and compositions for mediating gene silencing
03/18/2010WO2009138985A3 Coupling agents for the synthesis of polypeptides and polynucleotides
03/18/2010WO2009137145A3 Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods
03/18/2010WO2009134322A3 Lysine riboswitch and compositions and uses thereof
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 899